Dodge & Cox ownership in ZBH / Zimmer Biomet Holdings, Inc.

짐머 바이오메트 홀딩스, Inc.

CH ˙ SWX ˙ US98956P1021

CHF157.00 ↑7.77 (5.37%)

2021-04-13
주가

Security	CH:ZBH / Zimmer Biomet Holdings, Inc.
Institution	Dodge & Cox
Latest Disclosed Ownership	22,097,463 shares
Ownership	11.20%

2025-08-13 - Dodge & Cox has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 22,097,463 shares of Zimmer Biomet Holdings, Inc. (CH:ZBH). This represents 11.2 percent ownership of the company. In their previous filing dated 2025-05-06 , Dodge & Cox had reported owning 20,087,118 shares, indicating an increase of 10.01 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2025-08-13	2025-08-13	13G/A	20,087,118	22,097,463	10.01	11.20	9.80
2025-05-06	2025-05-06	13G/A	19,118,436	20,087,118	5.07	10.20	6.25
2025-02-13	2025-02-13	13G/A	17,073,791	19,118,436	11.98	9.60	14.29
2024-11-13	2024-11-13	13G/A	11,474,535	17,073,791	48.80	8.40	52.73
2024-02-13	2024-02-13	13G		11,474,535		5.50

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-14	2026-03-31	13F	Zimmer Biomet Holdings	COM	98956P102	23,542,700	35,851	0.15	2,128,731	0.71	1.1698
2026-02-13	2025-12-31	13F	Zimmer Biomet Holdings	COM	98956P102	23,506,849	290,676	1.25	2,113,736	-7.57	1.1410
2025-11-13	2025-09-30	13F	Zimmer Biomet Holdings	COM	98956P102	23,216,173	1,118,710	5.06	2,286,793	13.46	1.2339
2025-08-13	2025-06-30	13F	Zimmer Biomet Holdings	COM	98956P102	22,097,463	2,533,009	12.95	2,015,510	-8.98	1.1325
2025-05-14	2025-03-31	13F	Zimmer Biomet Holdings	COM	98956P102	19,564,454	446,018	2.33	2,214,305	9.65	1.2621
2025-02-13	2024-12-31	13F	Zimmer Biomet Holdings	COM	98956P102	19,118,436	2,044,645	11.98	2,019,480	9.57	1.1752
2024-11-13	2024-09-30	13F	Zimmer Biomet Holdings	COM	98956P102	17,073,791	328,161	1.96	1,843,116	1.41	1.0423
2024-08-13	2024-06-30	13F	Zimmer Biomet Holdings	COM	98956P102	16,745,630	326,360	1.99	1,817,403	-16.13	1.0907
2024-05-14	2024-03-31	13F	Zimmer Biomet Holdings	COM	98956P102	16,419,270	4,944,735	43.09	2,167,015	55.18	1.2571
2024-02-22	2023-12-31	13F/A-1	Zimmer Biomet Holdings	COM	98956P102	11,474,535	6,647,810	137.73	1,396,451	157.81	0.8863
2024-02-15	2023-12-31	13F	Zimmer Biomet Holdings	COM	98956P102	11,474,535	6,647,810		1,396,451		0.8877
2023-11-14	2023-09-30	13F	Zimmer Biomet Holdings	COM	98956P102	4,826,725	-37,775	-0.78	541,655	-23.52	0.3650
2023-08-14	2023-06-30	13F	Zimmer Biomet Holdings	COM	98956P102	4,864,500	-57,250	-1.16	708,271	11.38	0.4726
2023-05-12	2023-03-31	13F	Zimmer Biomet Holdings	COM	98956P102	4,921,750	-25,700	-0.52	635,890	0.81	0.4333
2023-02-14	2022-12-31	13F	Zimmer Biomet Holdings	COM	98956P102	4,947,450	-407,050	-7.60	630,800	12.68	0.4326
2022-11-10	2022-09-30	13F	Zimmer Biomet Holdings	COM	98956P102	5,354,500	-56,100	-1.04	559,813	-1.52	0.4242
2022-08-12	2022-06-30	13F	Zimmer Biomet Holdings	COM	98956P102	5,410,600	3,077,685	131.92	568,438	90.51	0.3935
2022-05-13	2022-03-31	13F	Zimmer Biomet Holdings	COM	98956P102	2,332,915	2,332,915		298,380		0.1813

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.